Related references
Note: Only part of the references are listed.Vitamin D and Microbiota: Is There a Link with Allergies?
Giuseppe Murdaca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cutaneous pseudolymphoma-A review on the spectrum and a proposal for a new classification
Christina Mitteldorf et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
Pau Bosch-Nicolau et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
J. W. Baddley et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
Kim Papp et al.
LANCET (2017)
Cutaneous Pseudolymphoma in a Patient With Crohn’s Disease Under Infliximab
Sofia Carvalhana et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Anti-Tumour Necrosis Factor-Induced Visceral and Cutaneous Leishmaniasis: Case Report and Review of the Literature
Alba Catala et al.
DERMATOLOGY (2015)
Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: Use of cyclosporine as a rescue therapy
Gilles Safa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats
Christian Bogdan
ANNALS OF THE RHEUMATIC DISEASES (2012)
Cutaneous pseudolymphoma induced by adalimumab and reproduced by infliximab in a patient with arthropathic psoriasis
S. Imafuku et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human
Gregory Michel et al.
ACTA TROPICA (2011)
The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases
Giuseppe Murdaca et al.
INTERNAL AND EMERGENCY MEDICINE (2011)
Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany
Gerhard Boecken et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2011)
Cutaneous Lymphoid Hyperplasia Associated with Leishmania panamensis Infection
Sebastiano Recalcati et al.
ACTA DERMATO-VENEREOLOGICA (2010)
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Zehra Kaymakcalan et al.
CLINICAL IMMUNOLOGY (2009)
Cutaneous pseudolymphoma in association with Leishmania donovani
M. J. Flaig et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Clinical response to alimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
Kenneth B. Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
A leishmanin skin test survey in the human population of l'Alacanti Region (Spain): implications for the epidemiology of Leishmania infantum infection in southern Europe
L Moral et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
Share Paper
